1. Home
  2. IMUX vs EHTH Comparison

IMUX vs EHTH Comparison

Compare IMUX & EHTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • EHTH
  • Stock Information
  • Founded
  • IMUX 2016
  • EHTH 1997
  • Country
  • IMUX United States
  • EHTH United States
  • Employees
  • IMUX N/A
  • EHTH N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • EHTH Specialty Insurers
  • Sector
  • IMUX Health Care
  • EHTH Finance
  • Exchange
  • IMUX Nasdaq
  • EHTH Nasdaq
  • Market Cap
  • IMUX 90.4M
  • EHTH 105.1M
  • IPO Year
  • IMUX N/A
  • EHTH 2006
  • Fundamental
  • Price
  • IMUX $0.95
  • EHTH $3.84
  • Analyst Decision
  • IMUX Strong Buy
  • EHTH Buy
  • Analyst Count
  • IMUX 5
  • EHTH 4
  • Target Price
  • IMUX $7.50
  • EHTH $8.50
  • AVG Volume (30 Days)
  • IMUX 1.1M
  • EHTH 723.1K
  • Earning Date
  • IMUX 08-07-2025
  • EHTH 08-06-2025
  • Dividend Yield
  • IMUX N/A
  • EHTH N/A
  • EPS Growth
  • IMUX N/A
  • EHTH N/A
  • EPS
  • IMUX N/A
  • EHTH N/A
  • Revenue
  • IMUX N/A
  • EHTH $547,491,000.00
  • Revenue This Year
  • IMUX N/A
  • EHTH $1.84
  • Revenue Next Year
  • IMUX N/A
  • EHTH $6.72
  • P/E Ratio
  • IMUX N/A
  • EHTH N/A
  • Revenue Growth
  • IMUX N/A
  • EHTH 16.19
  • 52 Week Low
  • IMUX $0.56
  • EHTH $3.18
  • 52 Week High
  • IMUX $2.11
  • EHTH $11.36
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 53.93
  • EHTH 53.52
  • Support Level
  • IMUX $0.89
  • EHTH $3.41
  • Resistance Level
  • IMUX $1.00
  • EHTH $4.91
  • Average True Range (ATR)
  • IMUX 0.08
  • EHTH 0.34
  • MACD
  • IMUX -0.00
  • EHTH 0.04
  • Stochastic Oscillator
  • IMUX 71.43
  • EHTH 37.43

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

Share on Social Networks: